摘要
血管内物质侵入到脑中细胞外间隙,通过无血脑屏障(BBB)位点的内皮细胞并不仅移转脑脊髓液(CSF)还有与非-BBB位点毗邻的脑软细胞组织中的间隙液体(ISF)。很可能CSF可以通过蛛网膜绒毛和颗粒直接排进血液,同样由脑中的蛛网膜下腔和淋巴管进入淋巴结。然而,ISF通过沿毛细血管和动脉通路进入到颈部淋巴结。按照提出的流动路径,似乎对维持正常的脑部功能是有害的,可以合理的推断阻塞流体的这些路径有可能诱导一些脑部的功能素乱,例如阿尔治海默氏病。根据这些假设的通路去消除脑中的β-淀粉样蛋白,神经中主要的β-淀粉样蛋白多肽可被肽酶降解,由脑实质流出进入血液通过外向转移体定位于脑血管,通过血管周围的通路排出进入颈部淋巴结,或者被其他类型的脑部细胞占用。对于血管周通路,ISF包括β-淀粉样蛋白多肽扩散到脑实质细胞外间隙,进入毛细血管基底膜,进入到动脉被囊介质,并排除脑部。这篇综述中,阐述了这些用于清除包括β-淀粉样蛋白在内的流体从脑部进入血液的通路,并简单讨论了这些通路异常和脑疾病之间的关系。
关键词: β-淀粉样蛋白,血脑屏障,脑脊髓液,间隙液体,血管周排放。
Current Medicinal Chemistry
Title:Clearance of Beta-Amyloid in the Brain
Volume: 21 Issue: 35
Author(s): Masaki Ueno, Yoichi Chiba, Koichi Matsumoto, Toshitaka Nakagawa and Hiroshi Miyanaka
Affiliation:
关键词: β-淀粉样蛋白,血脑屏障,脑脊髓液,间隙液体,血管周排放。
摘要: Intravascular substances invade extracellular spaces in the brain via endothelial cells in the sites without bloodbrain barrier (BBB) and move not only in the cerebrospinal fluid (CSF) but also in the interstitial fluid (ISF) of brain parenchyma adjacent to non-BBB sites. It is likely that CSF drains directly into the blood via arachnoid villi and granulations and also to lymph nodes via subarachnoid spaces in the brain and nasal lymphatics, whereas ISF drains to cervical lymph nodes through pathways along vascular wall of capillaries and arteries. As the supposed pathways of fluids seem to be critical for the maintenance of normal brain function, it is reasonable to suspect that an obstacle to the passage of fluids through these pathways likely induces some kinds of brain dysfunction such as Alzheimer’s disease. According to assumed pathways for the elimination of amyloid-β (Aβ) from the brain, Aβ peptides produced mainly in neurons are degraded by peptidases, flow out of the brain parenchyma into the blood through efflux transporters located in cerebral vessels, drain through perivascular pathways into the cervical lymph nodes, or are taken up by some kinds of cells in the brain. As for the perivascular pathways, ISF including Aβ peptides diffuses in the extracellular spaces of the brain parenchyma, enters basement membranes of capillaries, passes into the tunica media of arteries, and drains out of the brain. In this review, these pathways for the clearance of fluids including Aβ from the brain into the blood are briefly reviewed and the relationship between dysfunction of these pathways and brain diseases is discussed.
Export Options
About this article
Cite this article as:
Ueno Masaki, Chiba Yoichi, Matsumoto Koichi, Nakagawa Toshitaka and Miyanaka Hiroshi, Clearance of Beta-Amyloid in the Brain, Current Medicinal Chemistry 2014; 21 (35) . https://dx.doi.org/10.2174/0929867321666141011194256
DOI https://dx.doi.org/10.2174/0929867321666141011194256 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Isolation of the Antibacterial Agent Viridiol from the Mangrove Endophytic Fungus Hypocrea virens, as Monitored by a Biologic Assay Against Escherichia coli and NMR Spectroscopy
Current Biotechnology Tuberculosis - Present Medication and Therapeutic Prospects
Current Medicinal Chemistry Disentangling the Intricacies of Migraine: A Review
CNS & Neurological Disorders - Drug Targets Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Advances in TB Vaccinology
Current Respiratory Medicine Reviews Editorial [Hot topic:Targeted Alpha Particle Therapy (Guest Editors: Ganesan Vaidyanathan and Roy Larsen)]
Current Radiopharmaceuticals Lignans and Neolignans Anti-tuberculosis Identified by QSAR and Molecular Modeling
Combinatorial Chemistry & High Throughput Screening Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome
Current Pharmaceutical Design Vaccine Development for Group A Streptococcus Infections and Associated Diseases
Current Drug Targets Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) The Expanding Universe of γ δ T Lymphocytes: Subsets, Generation and Function
Current Immunology Reviews (Discontinued) Current Status and Future of Antifungal Therapy for Systemic Mycoses
Recent Patents on Anti-Infective Drug Discovery Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System
Current Neuropharmacology Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology N-Terminal Pro-C-Type Natriuretic Peptide: The Novel Marker in Selected Disease Units
Protein & Peptide Letters A Case of Neurosarcoidosis Mimicking Brain Tumor
Current Medical Imaging